Kayal M, Jimenez D, Huang J, Spencer EA, et al. Comparable 12-Week and Superior 24-Week Remission with Risankizumab vs Ustekinumab for Crohn's-Like Disease of the Pouch. Clin Gastroenterol Hepatol 2025 Nov 7:S1542-3565(25)00935.
PMID: 41207520